Michal Carmiel

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Vlad Ratziu, Ladrón de Guevara, Rifaat Safadi et al. · Nature Medicine · 2021 · 215 citations · Full text

Medicine, Internal Medicine, Pharmacology +10

The Real-World Israeli Experience of Treating Chronic Hepatitis C, Genotype 1 Patients with Advanced Fibrosis with Paritaprevir/Ritonavir/Ombitasvir, Dasabuvir with or without Ribavirin: A Large Multi-Center Cohort

E. Zuckerman, E. Ashkenasi, Y. Kovalev et al. · Journal of Hepatology · 2016 · 24 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study

Markus Cornberg, Adriana Ahumada, Alessio Aghemo et al. · Advances in Therapy · 2022 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Vascular and Biliary Abnormalities Mimicking Cholangiocarcinoma in Patients With Cavernous Transformation of the Portal Vein

Ada Kessler, Moshe Graif, Fred M. Konikoff et al. · Journal of Ultrasound in Medicine · 2007 · 15 citations

Medicine, Oncology, Radiology +16